Modulation of glyceraldehyde-3-phosphate dehydrogenase in Salmonella abortus equi lipopolysaccharide-treated mice.
Nitric oxide (NO) is known to inhibit glyceraldehyde-3-phosphate dehydrogenase enzyme activity caused by an NAD(+)-dependent posttranslational protein modification mechanism. In order to study a possible similar protein modification under in vivo conditions, mice were injected with bacterial endotoxin known to endogenously generate NO. In endotoxin-treated mice glyceraldehyde-3-phosphate dehydrogenase enzyme activity was significantly reduced in cytosolic fractions of heart and spleen, compared to 100,000 x g supernatants of untreated control animals. Enzyme activity was unaffected in lung and kidney cytosol of the endotoxin-treated group. Employing the differential NAD(+)-dependent labelling method, glyceraldehyde-3-phosphate dehydrogenase in heart and spleen cytosol of the endotoxin-treated group, versus the control group, had been endogenously modified. These changes were not observed in lung and kidney cytosol of endotoxin-challenged animals. Using Western blot analysis no significant changes in the amount of protein (glyceraldehyde-3-phosphate dehydrogenase) in control versus endotoxin-treated animals was detectable. Since an endogenously NAD(+)-modified glyceraldehyde-3-phosphate dehydrogenase occurred in endotoxin-treated mice, at least in some organs, this NO-stimulated posttranslational protein modification mechanism seems to function under in vivo conditions. A covalent protein modification mechanism, rather than differences in the amount of the protein is likely to cause changes in enzyme activity.